Sedative and anticonvulsant activities of the aqueous root extract of Sanseviera liberica Gerome & Labroy (Agavaceae)

被引:18
作者
Adeyemi, Olufunmilayo O. [1 ]
Yemitan, Omoniyi K.
Adebiyi, Olayemi O.
机构
[1] Univ Lagos, Coll Med, Dept Pharmacol, Lagos 12003, Nigeria
[2] Lagos State Univ, Coll Med, Dept Pharmacol, Lagos 21266, Nigeria
关键词
sanseviera liberica; sedative; anticonvulsant; strychnine; picrotoxin; bicuculline;
D O I
10.1016/j.jep.2007.05.007
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The central nervous system (CNS) depressant and anticonvulsant activities of the aqueous root extract of Sanseviera liberica (ASL) were investigated on various animal models including pentobarbitone sleeping time and hole-board exploratory behaviour for sedation tests, and strychnine, picrotoxin, bicuculline and pentylenetetrazole-induced convulsions in mice. ASL (100-400mg/kg, p.o.), like chlorpromazine HCl (1 mg/kg, i.m.), produced a dose-dependent prolongation of pentobarbitone sleeping time and suppression of exploratory behaviour. ASL (100 and 200 mg/kg) produced dose-dependent and significant (P < 0.05) increases in onset to clonic and tonic convulsions, and at 400 mg/kg, showed complete protection against seizures induced by strychnine, picrotoxin and bicuculline, but not with pentylenetetrazole. ASL up to 10 g/kg, p.o. did not produce death, but i.p. treatment produced mortalities with LD50 of 668.3 +/- 47.6 mg/kg. Preliminary phytochemical investigations of ASL revealed the presence of carbohydrates, alkaloids, saponins, reducing sugars and oils. The results indicate that ASL has sedative and anticonvulsant activities, therefore, justifying its use in traditional African medicine. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 14 条
  • [1] BIGGIO G, 1992, ADV BIOCHEM PSYCHOPH, V47, P281
  • [2] BLOOM FE, 1996, GOODMAN GILMANS PHAR, P267
  • [3] REMISSION OF EPILEPSY - RESULTS FROM THE NATIONAL GENERAL-PRACTICE STUDY OF EPILEPSY
    COCKERELL, OC
    JOHNSON, AL
    SANDER, JWAS
    HART, YM
    SHORVON, SD
    [J]. LANCET, 1995, 346 (8968) : 140 - 144
  • [4] VALIDITY OF HEAD-DIPPING AS A MEASURE OF EXPLORATION IN A MODIFIED HOLE-BOARD
    FILE, SE
    WARDILL, AG
    [J]. PSYCHOPHARMACOLOGIA, 1975, 44 (01): : 53 - 59
  • [5] GALE K, 1992, J CLIN NEUROPHYSIOL, V2, P267
  • [6] ANTIEPILEPTIC DRUG DEVELOPMENT .2. ANTICONVULSANT DRUG SCREENING
    KRALL, RL
    PENRY, JK
    WHITE, BG
    KUPFERBERG, HJ
    SWINYARD, EA
    [J]. EPILEPSIA, 1978, 19 (04) : 409 - 428
  • [7] DEVELOPMENT OF NEW PHARMACOLOGICAL AGENTS FOR EPILEPSY - LESSONS FROM THE KINDLING MODEL
    MCNAMARA, JO
    [J]. EPILEPSIA, 1989, 30 : S13 - S18
  • [8] Mujumdar AM, 2000, PHARM BIOL, V38, P13, DOI 10.1076/1388-0209(200001)3811-BFT013
  • [9] Rang H.P., 2000, PHARMACOLOGY, P604
  • [10] RICHENS A, 1993, TXB EPILEPSY, P495